Want to stay abreast of changes in prevention, care, treatment or research or other public health arenas that affect our collective response to the HIV epidemic? Or are you new to this field?
HIV.gov curates learning opportunities for you, and the people you serve and collaborate with.
Stay up to date with the webinars, Twitter chats, conferences and more in this section.
10-03-2019The FDA today approved Descovyin at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV...
04-09-2019The FDA approved Dovato, the first FDA-approved two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received treatment for HIV.
02-05-2016Editor’s Note: Reducing opioid misuse not only reduces deaths from overdose but is also key to reducing new HIV and viral hepatitis infections among perso…